It's been 38 days since the enrollment of the 195th patient was announced in a press release. Each patient takes 28 days to complete the trial so allowing time to get the 195th patient dosed, we should probably very close to the point where the DSMB can start looking at the data, if not at it already. The PR said mid-Oct for the interim results but I'm hoping things can be expedited.

(At the shareholders meeting Nader said something like every site having to deal with the data has slowed down enrollment overall but I was unclear what he meant and if it had any bearing on the timing of the interim analysis)